BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Geschäft · 13.12.20111 Min. Lesezeit

Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

The Food and Drug Administration (FDA) is announcing the availability of a draft report entitled "Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review" (literature review report). A literature review was conducted to address a requirement of the Patient Protection and Affordable Care Act (Affordable Care Act). FDA is publishing the literature review report to allow the public to provide comment on the report as it relates to the Affordable Care Act.

Originalsprache der Quelle: Federal Register — Health and Human ServicesOriginalquelle öffnen →

Weitere Themen

Business-Analysen →